Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

Recruiting Observational Study
Cutaneous T-Cell Lymphoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Instituto de Investigación Biomédica de Salamanca · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Identification and quantitation of circulating tumor cells in patients with cutaneous T-cell lymphoma -mycosis fungoides (MF)/Sézary syndrome (SS)- are required for diagnosis and precising the actual staging and response to treatment. The current flow cytometry techniques used in clinical laboratories do not correctly allow to compare results in a clinical setting. Furthermore, now we know that th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with cutaneous T-cell lymphoma * Over 18 years old * Sign the informed consent Exclusion Criteria: * Under 18 years old * Do not sign the informed consent
Contacts

Julia M Almeida Parra, Prof.

+34 923 29 45 00

jalmeida@usal.es

CONTACT

Ricardo López Pérez, PhD

+34 923 29 12 00

uicec.gestion@ibsal.es

CONTACT